The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection.
about
A Compendium for Mycoplasma pneumoniaeFulminant and Fatal Multiple Organ Failure in a 12-Year-Old Boy With Mycoplasma pneumoniae InfectionClinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype.Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia.Increased risk of refractory Mycoplasma pneumoniae pneumonia in children with atopic sensitization and asthma.Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implicationsVariation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumoniaAdjunct corticosteroids in children hospitalized with community-acquired pneumoniaEarly Additional Immune-Modulators for Mycoplasma pneumoniae Pneumonia in Children: An Observation Study.Efficacy of increasing dosages of clarithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia.Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumoniaTreatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.Hemophagocytic Syndrome Associated with Mycoplasma pneumoniae Pneumonia.Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in ChildrenImmunomodulatory effects of macrolides during community-acquired pneumonia: a literature review.Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia.Prediction of Bronchial Mucus Plugs Formation in Patients with Refractory Mycoplasma Pneumoniae Pneumonia.Early treatment with corticosteroids in patients with Mycoplasma pneumoniae pneumonia: a randomized clinical trial.Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China.Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.Mycoplasma pneumoniae pneumonia in children.Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia?Mycoplasma infections in children: an update.Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in children.Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia.Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children.
P2860
Q26752589-9954D33F-C3CE-4BA2-8164-2195CD37CE78Q33399001-D42334CB-C86C-404F-8ACD-0EB8C8A7B23FQ33534452-3E9B147F-F8D3-4794-86F0-6012323CEC1CQ33625962-ECAD6BB8-294B-47FF-9451-3A76DD038A61Q33969439-E6851C7C-8A9A-4AED-98D9-C9DF2A70568EQ34023899-979103DB-C908-409C-9046-D88BA7AE4965Q34172141-4D5B80B6-8CA7-4CFC-9809-4D00C01092EAQ34285366-762638E7-A8E4-43C4-839C-B7841166D6F3Q34512999-61FBFDF6-84A7-4D7A-928D-F78D63F20A86Q34838916-F435AC4B-03A6-47DF-B02E-5AB417937AF1Q35210467-61AA31D1-507A-443D-A5D6-08305D97D7DCQ36191631-BCC9C576-DDC1-45DF-98CA-1F4FEF1216CFQ36406243-349ED213-B4A7-4058-A329-9E4DD39796FCQ37067730-F7B17284-5A42-4858-A1D0-94B4D028B92FQ37144834-81912D1E-17F9-4C49-BA2B-AF0B8508C141Q37435982-7CDDA38D-034C-456D-851E-26C96E5BCB2CQ37970666-FF25EF19-6EAB-40F7-9BAF-D2FE30A0B67BQ39850842-11015711-75BA-4672-9E75-7BC2EBD76713Q40086915-5C5EE748-E083-4F86-B1A9-33F60E516978Q40211289-CADD5FAD-EE33-4436-8402-D1FC0F4F897EQ40241073-1F3F9FFB-652B-43EA-9DF5-71ACE69E03D1Q40749497-86219C5C-B158-4DAF-97CE-9504EF115C70Q41553397-9D8200AC-A210-4BB3-A9E9-B60433A56D08Q44127294-80B1C5A8-AE8C-49E7-A128-8849C828694CQ46102813-A9A91715-0EC3-4AA0-B004-623A5D757036Q46477550-00385D6B-C9CE-4E04-A6F4-89FF2E492C65Q47148223-403C0D7D-9552-4E3B-9D25-061A0B796B71Q47988062-804EC6C9-7C58-4ECB-B0FA-8686975C3A7D
P2860
The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The impact of steroids given w ...... umoniae respiratory infection.
@en
type
label
The impact of steroids given w ...... umoniae respiratory infection.
@en
prefLabel
The impact of steroids given w ...... umoniae respiratory infection.
@en
P2093
P2860
P50
P356
P1476
The impact of steroids given w ...... eumoniae respiratory infection
@en
P2093
C M Salvatore
C Techasaensiri
N Principi
P2860
P304
P356
10.1086/591915
P407
P577
2008-10-01T00:00:00Z